SightfileU.S. market data from official filings
Companies › QGEN
QIAGEN NV (QGEN)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001015820 · EDGAR filings · Updated 2026-06-05
QIAGEN NV (QGEN) has 339 institutional managers reporting positions valued at $4.98B per the latest 13F reporting period.
Institutional managers
339
Reported 13F value
$4.98B
Latest updates
- 2026-06-05 — SCHEDULE 13G/A filed
- 2026-06-01 — SD filed
- 2026-05-08 — Foreign issuer report (6-K) filed
- 2026-05-08 — Foreign issuer report (6-K) filed
- 2026-05-01 — Foreign issuer report (6-K) filed
- 2026-03-20 — IRANNOTICE filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, QIAGEN NV has 339 institutional holders.
Related companies
LANTHEUS HLDGS INC (LNTH) · AVANTOR INC (AVTR) · DIANTHUS THERAPEUTICS INC (DNTH) · CHEMED CORP NEW (CHE) · BRUKER CORP COM (BRKR) · ENVISTA HOLDINGS CORPORATION (NVST)
See full history, cross-references and alerts on SightfileSightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-05.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-05.